Influenza virus delta NS1 vaccine

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameInfluenza virus delta NS1 vaccine

Drug Alias NameFluVacc,FluVacc-DNS1流感病毒 δ NS1蛋白疫苗Seasonal influenza virus vaccine,deltaFLU LAIVSeasonal influenza vaccine deltaFLUInfluenza A virus vaccine H1N1 +[15]

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza in BirdsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryRussian FederationAustria

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGreen Hills Biotechnology

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAvir Green Hills Biotechnology Ag

Active IndicationsN/A

Inactive IndicationsInfluenza in BirdsInfluenza, Human

Other Information

ATC CodeN/A